Stockreport

Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma [Yahoo! Finance]

Adicet Bio, Inc.  (ACET) 
Last adicet bio, inc. earnings: 5/3 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: aceto.com/ir/index.html
PDF Phase 1 clinical study to evaluate safety and anti-tumor activity of ADI-270 in relapsed/refractory RCC patients Phase 1 clinical study to be initiated in 2H 2024; pr [Read more]